Sanofi $SNY Shares Acquired by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. raised its holdings in Sanofi (NASDAQ:SNY) by 31.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 523,168 shares of the company’s stock after purchasing an additional 126,381 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Sanofi were worth $25,353,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Flagship Harbor Advisors LLC purchased a new stake in Sanofi in the fourth quarter valued at approximately $25,000. Measured Wealth Private Client Group LLC purchased a new stake in Sanofi during the 3rd quarter worth about $29,000. Palisade Asset Management LLC acquired a new stake in Sanofi in the third quarter valued at approximately $30,000. Annis Gardner Whiting Capital Advisors LLC raised its holdings in shares of Sanofi by 544.4% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 696 shares of the company’s stock valued at $34,000 after purchasing an additional 588 shares in the last quarter. Finally, Larson Financial Group LLC raised its stake in Sanofi by 48.9% in the fourth quarter. Larson Financial Group LLC now owns 810 shares of the company’s stock valued at $39,000 after buying an additional 266 shares in the last quarter. 14.03% of the stock is owned by hedge funds and other institutional investors.

Sanofi Stock Performance

NASDAQ SNY opened at $41.78 on Tuesday. The company has a market capitalization of $101.29 billion, a PE ratio of 11.67, a price-to-earnings-growth ratio of 1.04 and a beta of 0.34. Sanofi has a twelve month low of $40.89 and a twelve month high of $52.68. The company has a current ratio of 1.01, a quick ratio of 0.22 and a debt-to-equity ratio of 0.17. The business’s 50-day moving average price is $44.59 and its 200 day moving average price is $46.22.

Sanofi Increases Dividend

The company also recently announced an annual dividend, which was paid on Wednesday, June 3rd. Investors of record on Monday, May 4th were issued a $2.4225 dividend. The ex-dividend date was Monday, May 4th. This is an increase from Sanofi’s previous annual dividend of $2.04. This represents a yield of 559.0%. Sanofi’s payout ratio is 49.16%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on SNY shares. Citigroup restated a “neutral” rating on shares of Sanofi in a research report on Monday, April 13th. Morgan Stanley set a $52.00 price objective on Sanofi in a research note on Friday, May 1st. BNP Paribas Exane cut shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 target price for the company. in a research note on Monday, April 20th. Weiss Ratings raised Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 13th. Finally, Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a research note on Thursday, March 19th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $51.00.

Sanofi Company Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.